Fig. 19From: PROTAC’ing oncoproteins: targeted protein degradation for cancer therapyStructures of GFP-KRAS and KRAS Degraders. Targeting ligands and E3 ligase ligands are highlighted in yellow and gray, respectivelyBack to article page